(Nasdaq: AIFA) (the “Company” or “AIFA”) today provided a further update regarding its acquisition transaction involving HyalRoute Communication Group Limited (“HyalRoute” or the “HyalRoute Group”).
The Dexterra Group cleaning contractor employing workers at the Greater Vancouver SkyTrain line are falling short and TransLink needs to take action, said SEIU Local 2 at a TransLink Board Meeting ...
SNOWLINE GOLD CORP. (TSX: SGD) (OTCQB: SNWGF) (the “Company ” or “Snowline ”) is pleased to announce the results of voting at its Annual General and Special Meeting of Shareholders (“Meeting ”) held ...
Fabric.AI, Inc. (Nasdaq: FABC) is a fabless semiconductor company developing MicroLED-based optical interconnects designed to ...
NAPC Defense, Inc. (OTCID: BLIS) ("NAPC Defense" or the "Company"), a U.S.-licensed defense manufacturer with exclusive ...
S&P Global Ratings has upgraded ratings on several subsidiaries of Freedom Holding Corp., a Nasdaq-listed international investment and technology group. The ratings on Freedom Finance JSC, Freedom ...
STARTRADER has added SPCX CFD (Space Exploration Technologies Corp.) to its trading platform, making the instrument available ...
Probook, the AI Operating System for home service businesses, today announced $40 million in funding. The investment ...
KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery ...
BOISE, Idaho, June 24, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its third quarter of fiscal 2026, which ended May 28, 2026. Revenue of $41.46 billion ...
Colin Reed, Executive Chairman of Ryman Hospitality Properties said, “We are incredibly proud of our OEG business and of our role as stewards of these historic and iconic brands, which are deeply ...
Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment ...